Search Trials

Order


Status


885 results


Recruiting

Start date: Oct. 19, 2021

This project is designed to examine the neuronal KCNQ2/3 potassium (K+) channel subtype as a novel treatment target for mood disorders through the administration of the KCNQ-selective channel opener XEN1101 … Read More

BCM Role: Collaborator

Recruiting

Start date: Oct. 18, 2021

All patients will receive standard medical care and no experimental interventions will be performed. The Pathfinder Overtube is already being used to assist in polyp removal at our center and … Read More

BCM Role: Lead Sponsor

Recruiting

Start date: Oct. 11, 2021

This is a single arm (non-randomized) first-in-man pilot study to evaluate the safety and feasibility of delivering a dendritic cell vaccine in nine to twenty-four (n=9-24) adult patients diagnosed with … Read More

BCM Role: Collaborator

Not Yet Recruiting

Start date: Oct. 1, 2021

Tuberculosis (TB) continues to be a leading cause of morbidity and mortality among children and people living with HIV (PLHIV). Despite significant progress in TB diagnostics, improvement of childhood TB … Read More

BCM Role: Collaborator

Withdrawn

Start date: Oct. 1, 2021

Screening: All patients undergoing either elective or emergency cardiac surgery will be screened against the eligibility criteria. Research Sample Collection: Blood and urine will be collected for the first 48 … Read More


Enrolling By Invitation

Start date: Sept. 30, 2021

The Rett Syndrome Global Registry is a fully remote, global, caregiver-reported registry intended to meet the needs of caregivers, clinicians and researchers, and therapeutic developers with the goal to increase … Read More

BCM Role: Collaborator

Not Yet Recruiting

Start date: Sept. 15, 2021

More treatments are needed to target insomnia in Veterans with Posttraumatic Stress Disorder. There is evidence to suggest that pimavanserin, a medication approved by the Food and Drug Administration for … Read More

BCM Role: Lead Sponsor

Not Yet Recruiting

Start date: Sept. 3, 2021

PBTC-059 is a multicenter, Phase I and Surgical study of the treatment HER2-specific CAR T cells for patients with refractory or recurrent ependymoma. Phase I The primary objectives of the … Read More

BCM Role: Collaborator

Not Yet Recruiting

Start date: Sept. 1, 2021

Earlier, healthy donors gave blood for us to make CD30.CAR-EBVST cells in the laboratory. These cells were grown and frozen and the investigators will select the donor which the investigators … Read More

BCM Role: Lead Sponsor

Not Yet Recruiting

Start date: Sept. 1, 2021

Osteogenesis imperfecta (OI) is a heritable connective tissue disorder leading to frequent fractures and bone deformities. In about 90% of individuals with OI, the disease is caused by dominant mutations … Read More

BCM Role: Lead Sponsor